Discontinued — last reported Q4 '21
Products & Services · Valuation allowance
ADUHELM — Valuation allowance
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2021
Last reportedQ4 2021Feb 3, 2022
Rolls up toTax Credit Carryforward Valuation Allowance
How to read this metric
An increase indicates management's reduced expectation of future economic benefits from the asset, often signaling potential impairment or poor commercial performance.
Detailed definition
Represents the contra-asset account used to reduce the carrying value of deferred tax assets or specific product-related...
Peer comparison
Standard accounting practice across industries, often disclosed in tax notes or asset impairment sections of financial reports for specific product lines.
Metric ID:
biib_segment_aduhelm_valuation_allowanceHistorical Data
1 periods
| Q4 '21 | |
|---|---|
| Value | $390.00M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's aduhelm — valuation allowance?
- Biogen (BIIB) reported aduhelm — valuation allowance of $390.00M in Q4 2021.
- What does aduhelm — valuation allowance mean?
- A reduction in the recorded value of an asset to reflect the risk that it may not be fully recovered.